$134.80
Closed
-(-)

At close

Financial advisor consultation illustration
Get professional financial guidance

Schedule your free first call with a financial advisor on CUSP Wealth
*T&Cs apply

About

AptarGroup, Inc. engages in the design, manufacture, drug delivery, consumer product dispensing, sealing and active packaging solutions, and services for the prescription drug, consumer health care, injectable, active packaging, beauty, personal care, home care, and food and beverages industries. The company is headquartered in Crystal Lake, Illinois and currently employs 14,000 full-time employees. The firm serves diversified end markets including pharmaceutical, fragrance, facial skincare, color cosmetics, food, beverage, personal care, and home care. The company also manufactures and sells elastomeric primary packaging components. The company operates through three segments, which include Pharma segment, Beauty segment, and Closures segment. The Pharma segment is a supplier of nasal drug delivery spray pumps and metered dose inhaler valves (MDIs) to the pharmaceutical and health care markets worldwide. The Beauty segment sells pumps, airless systems and valves to the fragrance, color cosmetics, facial skincare, personal care, and home care markets. The Closures segment includes dispensing and non-dispensing solutions that enable product delivery without removal of the cap and are used across multiple consumer end markets.
Country

US

CEO

Mr. Stephan Tanda

IPO date

1993

Employees

14,000

ISIN

US0383361039

Key stats

Open

$132.96

Volume

400.54K

Market cap

$8.57B

Prev. close

$134.80

Impl / hst vl

-

Open interest

$0.00

$132.96

Day’s Range

$135.12

$110.95

52W Range

$146.91

Valuation

55
Valuation score
Fairly Valued
P/E
23.34
P/S
2.15
P/B
3.22
Current ratio
1.61
Debt / Equity
0.52
ROE
13.56%
Gross margin
35.61%
Income growth
20.50%
FCF growth
-13.44

Aug

20

Dividends

The last payment date was Aug 20, 2026

Div. per Share

$0.48

Div. Yield

0.36%

Payout Ratio

-

Div. Growth YoY

0.00%

Analysts estimates

Consensus rating
Strong buy

The average rating from top 5 analysts indicates that stock may significantly outperform the market

Str. Sell
Sell
Hold
Buy
Str. Buy
Avg. price target
$174.59
The top 7 analysts forecasts that 12-month price may increase by 29.52%, with a low of $156.55 and a high of $231.00
$156.55
Low
$174.59
Avg
$231.00
High
Current price

Earnings

Q2 ‘26 revenue
$1.03B
Q2 ‘26 net income
$87.57M
Revenue
Net income
Previous EPS
$1.19
Estimate EPS
$1.37
Actual EPS
Estimate EPS
Financial advisor consultation illustration
Get professional financial guidance

Schedule your free first call with a financial advisor on CUSP Wealth
*T&Cs apply